Recent News
Onglyza Lawsuits Mount, as Federal Heart Failure Claims Exceed 200
Product liability lawsuit filed over heart failure and other cardiovascular side effects allegedly associated with Onglyza and Kombiglyze XR continue to mount in courts throughout the United States. According to an update issued June 15th by the U.S. Judicial Panel … Continue reading
Chuck Norris, Wife Among Those Filing Lawsuits for Gadolinium Deposition Disease
The actor Chuck Norris and his wife, Gena, are among a growing number of plaintiffs who have filed MRI contrast dye lawsuits seeking compensation for “Gadolinium Deposition Disease,” a disorder allegedly caused by the retention of toxic gadolinium following an … Continue reading
European Regulator Holds Hearing on Fluoroquinolone Antibiotic Side Effects
The European Medicines Agency (EMA) recently convened a hearing to address the serious and often long-lasting side effects associated with fluoroquinolone antibiotics, including Levaquin, Cipro, and Avelox. The EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) has been reviewing fluoroquinolones since February … Continue reading
Endo International Finalizes Settlement to Resolve 1,300 Testosterone Lawsuits Involving Testim, Other Hormone Replacement Drugs
Endo International PLC has finalized a settlement that will resolve all known testosterone lawsuits involving Testim and other male hormone replacement drugs marketed by its Endo Pharmaceuticals and Auxilium Pharmaceuticals subsidiary. All of the lawsuits were filed on behalf of men … Continue reading
Florida Man Files Lawsuit Over Alleged DePuy Attune Knee Replacement Failure
Johnson & Johnson and its DePuy Synthes subsidiary continue to face a growing number of lawsuits over the allegedly defective Attune Knee Replacement System. One of the most recent DePuy Attune Knee lawsuits was filed on May 31st in the … Continue reading
Lawsuit Links Onglyza to Serious, Permanent Heart Injuries
A New Jersey man who allegedly developed serious and permanent cardiovascular injuries due to his use of Onglyza has joined the growing litigation involving the Type 2 diabetes drug. Saxagliptin Allegedly Caused Coronary Artery Disease, Congestive Heart Failure According to … Continue reading
Canadian Drug Regulator Warns of Possible Birth Defect Risk with Tivicay, Juluca & Triumeq
Health Canada has issued a new warning regarding the potential risk of serious birth defects in babies born to women treated with dolutegravir-containing HIV drugs, including Tivicay, Juluca, and Triumeq. The Canadian warning comes just weeks after the U.S. Food … Continue reading
Federal Regulator Warns Insurers to Watch Out for Suspicious Nuedexta Prescribing
The Centers for Medicare & Medicaid Services is asking insurers to be on the lookout for suspicious Nuedexta prescriptions, amid concerns that the antipsychotic medication is being used inappropriately to treat elderly dementia patients. What is Nuedexta? Marketed by Avanir Pharmaceuticals, … Continue reading
Proton Pump Inhibitor Lawsuit Parties Propose May 2020 for First Bellwether Trial
The federal court overseeing thousands of kidney damage lawsuits filed against the manufacturers of Nexium, Prilosec, PrevAcid, Dexilant, and Protonix has begun preparations for the multidistrict litigation’s first bellwether trials. According to a Plaintiffs’ Letter filed with the U.S. District … Continue reading
